Top compounds associated with response to BRAP


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00034 1
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.0003 1
mRNA XMD15-27 GDSC1000 pan-cancer AAC -0.00025 1
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.00016 1
mRNA QS11 CTRPv2 pan-cancer AAC 0.00025 1
mRNA Imatinib GDSC1000 pan-cancer AAC 0.00015 1
Download CSV